VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Clinical trial NCT07104383 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07104383
- Sponsor
- Viking Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-23
- Primary completion
- 2027-07-01
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.